#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital growth hormone deficiency Myeloproliferative neoplasm CDKL5 deficiency disorder Neuropathy peripheral Urea cycle disorder Primary mediastinal large B-cell lymphoma Hereditary angioedema with C1 esterase inhibitor deficiency Autoimmune hepatitis Immune-mediated enterocolitis Vulval cancer recurrent Stevens-Johnson syndrome Pulmonary alveolar haemorrhage Trigeminal neuralgia Porphyria non-acute Synovitis More trials…

    Learn about Rare Diseases

    Idiopathic pulmonary fibrosis – Basic Information Familial amyotrophic lateral sclerosis – Life with Disease X-linked lymphoproliferative syndrome – Trials in Disease Short-bowel syndrome – Trials in Disease Soft tissue sarcoma Angiosarcoma metastatic – Basic Information Alagille syndrome – Basic Information Adrenocortical carcinoma Wiskott-Aldrich syndrome – Treatment Hypereosinophilic syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Oxitriptan Deucravacitinib Pralsetinib Phenylephrine Hydrochloride Topotecan Hydrochloride Ofloxacin Hydrochloride TX000045 Prednisone Acetate NVG-2089 Lucerastat Specific Nucleic Acid Sna-Her2 Dexrazoxane Hydrochloride Nitrogen Ciltacabtagene Autoleucel Tegoprubart Cart45Ra-Nkg2D Cells Daunorubicin Buprenorphine CHLORMADINONE ACETATE Tuvusertib More therapies…

    Learn about Your Condition

    Bladder cancer Migraine Anal fistula Follicular lymphoma stage IV Nephrogenic anaemia Type 2 diabetes mellitus Adenocarcinoma gastric Asthma Alcoholism Cold type haemolytic anaemia Generalised anxiety disorder Acute respiratory failure Thymoma Eye inflammation Hypervolaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Phenylketonuria

  • A Study of Repinatrabit Compared to Placebo for Treatment of Patients with Phenylketonuria

    Recruiting

    3 1
    Czechia France Germany Italy The Netherlands Poland +1

  • Study of Long-Term Neurocognitive Outcomes in Children with Phenylketonuria Treated with Sepiapterin

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Phenylketonuria
    Investigated Drugs:
    • Sepiapterin
    France Ireland Poland Sweden

  • Study on the Long-Term Safety of PTC923 (Sepiapterin) for Patients with Phenylketonuria

    Not recruiting

    3 1 1
    Investigated Drugs:
    • (S)-2-Amino-6-(2-Hydroxypropanoyl)-7,8-Dihydropteridin-4(3H)-One
    Czechia Denmark France Germany Italy The Netherlands +4

  • Study Comparing Sepiapterin and Sapropterin for Treating Phenylketonuria in Patients Aged 2 Years and Older

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Phenylketonuria
    Investigated Drugs:
    • (S)-2-Amino-6-(2-Hydroxypropanoyl)-7,8-Dihydropteridin-4(3H)-One
    • Sapropterin Dihydrochloride
    Czechia Denmark France Germany Italy The Netherlands +3

  • Study of pegvaliase injections compared to diet control in adolescents aged 12-17 with phenylketonuria (PKU)

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Pegvaliase
    Germany

  • Study to Evaluate mRNA-3210 for Safety and Tolerability in Patients with Phenylketonuria

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Phenylketonuria
    Investigated Drugs:
    • Hydroxyzine Hydrochloride
    • Mrna-3210
    • Fexofenadine
    France Italy Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!